Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 4, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,943	1,829	1,318	1,260	985	1,154
Market Cap Growth	-13.94%	38.81%	4.57%	27.92%	-14.60%	-25.58%
Enterprise Value	2,446	2,240	1,629	1,521	1,202	1,377
Last Close Price	809.70	761.13	547.29	522.40	408.39	476.46
PE Ratio	195.28	188.91	144.98	156.37	-	317.23
PS Ratio	8.59	8.34	6.65	6.96	9.95	4.04
PB Ratio	64.37	62.17	56.46	23.92	21.97	19.94
P/TBV Ratio	64.37	62.17	56.46	23.92	21.97	19.94
EV/Sales Ratio	10.81	10.22	8.22	8.40	12.14	4.83
EV/EBITDA Ratio	136.65	122.73	80.79	77.41	-	75.98
EV/EBIT Ratio	196.56	180.50	123.64	102.35	-	119.74
EV/FCF Ratio	-22.17	-	-	-	-	-
Debt / Equity Ratio	20.83	16.23	16.82	6.55	5.35	3.94
Debt / EBITDA Ratio	35.13	25.86	18.95	16.49	-	11.72
Asset Turnover	0.36	0.40	0.39	0.39	0.23	0.69
Inventory Turnover	0.47	0.49	0.49	0.54	0.40	0.88
Quick Ratio	0.47	0.38	0.34	0.29	0.29	0.22
Current Ratio	0.92	0.91	0.88	0.92	0.87	0.89
Return on Equity (ROE)	37.67%	36.70%	23.91%	16.53%	-25.34%	6.29%
Return on Assets (ROA)	1.22%	1.41%	1.62%	2.01%	-1.07%	1.73%
Return on Capital (ROIC)	1.41%	1.68%	2.02%	2.72%	-1.60%	2.55%
Return on Capital Employed (ROCE)	35.60%	36.30%	44.70%	24.80%	-	17.00%
Earnings Yield	51.21%	0.53%	0.69%	0.64%	-1.32%	0.32%
FCF Yield	-567.85%	-3.72%	-2.68%	-5.93%	-0.55%	-1.10%
Dividend Yield	12.35%	0.13%	0.27%	0.19%	-	0.32%
Payout Ratio	5794.94%	34.91%	11.00%	18.61%	-	81.16%
Total Shareholder Return	12.35%	0.13%	0.27%	0.19%	-	0.32%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.